United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

29 Jul 2016
Change (% chg)

-- (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ACST.OQ


Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved in the development and commercialization of pharmaceutical applications of its licensed rights for... (more)
No analyst recommendations are available for ACST.OQ.


No Ratios Available.


  ACST.OQ Industry Sector
P/E (TTM): -- 38.77 39.28
EPS (TTM): -- -- --
ROI: -- 15.17 14.40
ROE: -- 16.12 15.47

BRIEF-Acasti posts qtrly loss per share of $0.29

* Qtrly loss per share $0.29 Source text for Eikon: Further company coverage:

Jul 11 2016

BRIEF-TomaGold buys Obalski property

* Signed an agreement to acquire Obalski property from David Malouf and 2736-1179 Quebec Inc

May 31 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Pechala's Reports
Provider : Wright Reports
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.